Need rapid startup support for vaccine and gene therapy trials?
Contact our Biosafety Services for IBC reviews in as little as 4.1 business days.
Looking for tips and best practices to keep research moving?
Download our free white paper Clinical Research in the COVID-19 Era: Methods for Continuity.
Need resources to support the research recovery
Download our growing list of capabilities.
Need support for your quality and compliance programs?
Contact us for in-person and remote GxP audits, consulting, and compliance support.
Assessing your research portfolio to keep research moving?
Contact us for proactive, collaborative guidance.
Need help establishing remote and virtual workflows?
Contact us for virtual resources and support services.
Have a study that’s stuck?
Transfer IRB oversight to Advarra until the original IRB is prepared to re-take oversight.
Have a research question about COVID-19?
Get a response within one business day.
Have a COVID-19 study?
Get priority reviews and the industry’s best turnaround times.
Working to adapt processes and policies for COVID-19?
Get expert support for virtual audits, document QC/QA, interim staffing, and more.
Watch our free educational on-demand webinars
- Ask Advarra Live: The Real-World Impact of COVID-19 on Research
- The New Normal: Considerations for Restarting Research
- Gene Therapy Research in the Age of COVID-19: Study Startup Success for Infectious Disease, Oncology, and Rare Disease Research
- COVID-19 Lessons Learned: Technology and Agility in the New Clinical Trial Landscape
- Accelerating the Recovery – IRB Review of Virtual Trial Technology
- Fireside Chat: The Future of Clinical Trials and Site Engagement
- Institutional Perspectives: Leveraging Technology to Meet Operational Goals During COVID-19
- From Reactive to Proactive: How to Evolve Your Research Program During a Global Crisis
- The New Urgency of Clinical Trials: How Oncology Leads the Evolution
- Study Startup Success for the New Generation of Genetically Engineered Vaccines
- Research Staffing Strategies During Challenging Times
